Dietary Supplement Use and Interactions with Tamoxifen and Aromatase Inhibitors in Breast Cancer Survivors Enrolled in Lifestyle Interventions
The use of dietary supplements is common in the general population and even more prevalent among cancer survivors. The World Cancer Research Fund/American Institute for Cancer Research specifies that dietary supplements should not be used for cancer prevention. Several dietary supplements have poten...
Guardado en:
Autores principales: | Maura Harrigan, Courtney McGowan, Annette Hood, Leah M. Ferrucci, ThaiHien Nguyen, Brenda Cartmel, Fang-Yong Li, Melinda L. Irwin, Tara Sanft |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6047a53df20342239f733b7280464583 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Cost-effectiveness of Tamoxifen, Aromatase Inhibitor, and Switch Therapy (Adjuvant Endocrine Therapy) for Breast Cancer in Hormone Receptor Positive Postmenopausal Women in India
por: Butani D, et al.
Publicado: (2021) -
Effect of aromatase inhibitors on sex differentiation and embryonic development in chicks
por: Salwan M. Abdulateef, et al.
Publicado: (2021) -
Randomized trial of weight loss on circulating ghrelin levels among breast cancer survivors
por: Leah Puklin, et al.
Publicado: (2021) -
Centchroman versus Tamoxifen in the management of mastalgia: a randomized controlled clinical trial
por: S Khadka, et al.
Publicado: (2016) -
Interactions of aromatase and seladin-1: A neurosteroidogenic and gender perspective
por: Kelicen-Ugur Pelin, et al.
Publicado: (2019)